Caas Capital Management LP Royalty Pharma PLC Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $22.4 Million - $26.2 Million	-619,939 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $30 Million - $35.1 Million	-752,184 Reduced 54.82%	619,939 $25.4 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $107 Million - $133 Million	-2,523,762 Reduced 64.78%	1,372,123 $59.9 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $130 Million - $180 Million	3,595,885 Added 1198.63%	3,895,885 $195 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $13.4 Million - $15.6 Million	300,000 New	300,000 $14.6 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.